How Many More Diabetes Cases Will New Screening Recs Catch?

Via Peters

Implementing recommendations for starting prediabetes and diabetes screening at age 35 would increase eligibility by about 6 to 7 percentage points, an analysis of National Health and Nutrition Examination Survey (NHANES) data indicated. In the study of nearly 4,500 asymptomatic adults, eligibility would increase from 36.3% to 43.0% when comparing […]

Cancer Screening: A Review of Guidelines from ACS, USPSTF

Via Peters

A side-by-side review of cancer screening guidelines from the American Cancer Society (ACS) and the US Preventive Services Task Force (USPSTF) anchored a presentation on cancer screening and barriers that increase health disparities for specific populations. Tracy Wyant, DNP, AOCN, CHPN, GERO-BC, EBP-C, CPPS, senior director of medical content, and […]

AI Shows Potential in Breast Cancer Screening Programs

Via Peters

March 31, 2022 — A major new study in Radiology shows that artificial intelligence (AI) is a promising tool for breast cancer detection in screening mammography programs. Mammograms acquired through population-based breast cancer screening programs produce a significant workload for radiologists. AI has been proposed as an automated second reader for […]

The Biochemistry of Breast Cancer Screening

Via Peters

The American Cancer Society (ACS) reported that 1 in 8 women will be diagnosed with breast cancer in her lifetime. There are almost 14 million new cases diagnosed and approximately 4.5 million deaths related to a breast cancer diagnosis each year. As the most common cancer diagnosed in women, efficient […]

A large trial of screening for gestational diabetes mellitus in the United States highlights the need to revisit the Australian diagnostic criteria

Via Peters

Recent trial results validate previous concerns about the IADPSG criteria for gestational diabetes The definition of gestational diabetes mellitus (GDM) varies considerably depending on the region where a woman lives, and considerable controversy remains on the best approach to diagnosis. A 2021 trial showed no benefit for women or infants […]